學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Getwell Pharmacy: Partner or Perish
內容大綱
In May 2022, Getwell Pharma India Private Limited was an independent neighbourhood pharmacy in Amritsar, India. Pharmacy retail in the country was largely dominated by traditional independent stores, until the emergence of pharmacy chains and e-pharmacies with scale advantage, extensive financial resources, large numbers of stock-keeping units, store brands, and new technology. These changes were making traditional pharmacies less attractive to customers, who were increasingly asking for heavy discounts to match those of the new competitors. However, the discounts were not manageable for independents that were positioned at the end of a long and fragmented supply chain and stuck with limited margins. As a result, Getwell Pharma India Private Limited was losing its customer base, despite offering quality products and services. With revenues and profits falling, should the company consider allowing a major competitor to absorb the business?